Biotec Medicaments India Private Limited
About Biotec Medicaments India Private Limited
Data last updated:
Biotec Medicaments India Private Limited is a private limited company based in Medchal, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 12 December 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24233TG2014PTC096816. Its GSTIN is 36AAGCB1282L1ZJ (Telangana). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Veera Sura Prasad Damarla and Shruti Prasad Arrivilla.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No 70(Part) 1st Floor Tsiic – Iala Phase 1 Cherlapally Village, Medchal, Telangana, India – 500051.
As per the financials filed for FY 2022, the company reported a revenue of ₹2.22 Lakh, a decline of 88% compared to the previous year. For the same year it recorded a net loss of ₹15.37 Lakh and EBITDA of -₹15.26 Lakh.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Biotec Medicaments India Private Limited's registered office is in Medchal, Telangana. Its e-mail address is in the company report.
- Email
- Registered AddressPlot No 70(Part) 1st Floor Tsiic – Iala Phase 1 Cherlapally Village, Medchal, Telangana, India – 500051
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Biotec Medicaments India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Biotec Medicaments India Private Limited
FY 2025 filings availableBiotec Medicaments India Private Limited reported revenue of ₹2.22 Lakh (down 88% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR)
Revenue fell 88% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹2.22 Lakh | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹15.26 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹15.37 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Biotec Medicaments India Private Limited, buy the company report.
Board of directors of Biotec Medicaments India Private Limited
Biotec Medicaments India has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Veera Sura Prasad Damarla Also directs: Bactolac Formulations Pvt Ltd | Director | 12 Dec 2014 | 11 Years 10 Months | Current |
| Shruti Prasad Arrivilla | Director | 25 Sep 2021 | 5 Years 1 Months | Current |
Auditor
Biotec Medicaments India Private Limited is audited by B R R & ASSOCIATES for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| B R R & ASSOCIATES | FY 2020 | 013012S |
Shareholding
The shareholding of Biotec Medicaments India Private Limited is on record for 4 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Biotec Medicaments India Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Biotec Medicaments India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Biotec Medicaments India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Biotec Medicaments India has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAGCB1282L1ZJ | Telangana | Active | 10 Apr 2021 |
| 27AAGCB1282L1ZI | Maharashtra | Active | 14 Feb 2022 |
To see the full GST registrations and return filing status of Biotec Medicaments India Private Limited, buy the company report.
Recent activity
Biotec Medicaments India Private Limited has 4 board changes on record since 2014: 2 appointments and 2 cessations. The latest: Shruti Prasad Arrivilla was appointed as Director on 25 Sep 2021.
Frequently asked questions
Biotec Medicaments India is an active private limited company based in Medchal, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 12 December 2014 (12+ years old) and is registered under CIN U24233TG2014PTC096816.
Biotec Medicaments India has 2 current directors:
- Veera Sura Prasad Damarla - Director
- Shruti Prasad Arrivilla - Director
The latest financial statements of Biotec Medicaments India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Biotec Medicaments India is 36AAGCB1282L1ZJ, registered in Telangana. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 27AAGCB1282L1ZI (Maharashtra).
The CIN (Corporate Identification Number) of Biotec Medicaments India is U24233TG2014PTC096816. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Biotec Medicaments India was incorporated on 12 December 2014, making it 12+ years old. It is registered with the Registrar of Companies, Hyderabad.
Shruti Prasad Arrivilla was appointed as Director on 25 Sep 2021. Syamala Rani Kanuri ceased to be Director on 25 Sep 2021. Dinesh Kumar Gadde ceased to be Director on 04 May 2015. Biotec Medicaments India has 4 board changes on record in total.
The registered office of Biotec Medicaments India is at Plot No 70Part 1st Floor Tsiic – Iala Phase 1 Cherlapally Village, Medchal, Telangana, India – 500051.
Biotec Medicaments India operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Biotec Medicaments India is compliant as of 20 September 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
